Companies › OGN

ORGANON & CO (OGN)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001821825 · EDGAR filings · Updated 2026-07-23

ORGANON & CO (OGN) has reported institutional ownership of 75.9%, with 604 institutional managers holding positions valued at $1.20B per the latest 13F reporting period.

Filings this week (1)

• 2026-07-23 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-17 — DEFA14A filed
• 2026-07-17 — Current report (8-K) filed
• 2026-06-17 — DEFM14A filed
• 2026-06-15 — Insider transaction reported (Form 4)
• 2026-06-15 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ORGANON & CO has 604 institutional holders and institutional ownership of 75.9%.

Insider activity

Insiders reported 122 transactions (7 buys, 0 sells) across 14 reporting insiders, with a net reported value of $1.15M.

Related companies

U S PHYSICAL THERAPY (USPH) · BIOHAVEN LTD F (BHVN) · CONMED CORP COM (CNMD) · MOONLAKE IMMUNOTHERAPEUTICS (MLTX) · SAVARA INC (SVRA) · GENERATE BIOMEDICINES INC (GENB)